Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04179721 · ClinicalTrials.gov registry record · NA
Reducing Behavioral and Psychological Symptoms of Dementia: Hospital Caregivers (Aim 2)
A NA study of Alzheimer's Disease and Related Dementias, sponsored by Northwell Health.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
- 2
- Study locations
NCT04179721 is a NA study of Alzheimer's Disease and Related Dementias that has completed, run by Northwell Health. The registered enrollment target is 54 participants, below the 1,629-participant average among 5 other Alzheimer's Disease and Related Dementias trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT04179721, a NA study of Alzheimer's Disease and Related Dementias, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
- 2
- Study locations
Study Summary
Persons with Alzheimer's Disease and Related Dementias (ADRD) account for 3.2 million hospital admissions per year and have over three times more hospitalizations than those without cognitive impairment, yet hospital caregivers (HCGs) are ill-prepared to manage patients with ADRD with less than 5% reporting mandatory dementia care training. Three-quarters of hospitalized persons with ADRD display Behavioral and Psychological Symptoms of Dementia (BPSD) associated with functional and cognitive decline, increased resource consumption, institutionalization, premature death, and caregiver burden. The overall objective is to test the preliminary efficacy of an innovative model of care, PES-4-BPSD, for reducing BPSD by empowering Patient Engagement Specialists (PES) to deliver dementia care for acutely-ill patients with ADRD. Traditionally, mental health assistants with training in crisis-prevention techniques provide care to psychiatric patients. On the intervention unit, these mental health assistants, as PES, purposefully engage patients with BPSD. In the pilot study, investigators found patients with cognitive impairment admitted to the PES unit were significantly less likely to require constant observation, chemical and physical restraints, suggesting improved management of BPSD. The central hypothesis is that PES-4-BPSD will improve the ability of PES to create an "enabling" milieu that addresses factors leading to BPSD and improves the experience of hospital caregivers. Guided by a social-ecological framework, PES-4-BPSD incorporates dementia education and training, environmental modifications-cohorting, increased staffing-PES, and staff support. The investigators' multidisciplinary research team is well-positioned to accomplish the following: Aim 1) Determine the preliminary efficacy of PES-4-BPSD for reducing BPSD during hospitalization (please refer to NCT# 04481568 for more details on this aim), and Aim 2) Evaluate whether dementia care training improves the pe
Conditions Studied
Interventions
- BEHAVIORAL PES-4-BPSD Model
- BEHAVIORAL The attention control condition
Study Locations (2)
New York
- Long Island Jewish Medical Center - Glen Oaks
- North Shore University Hospital - Manhasset
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2019-10-22 |
| Est. Completion | 2021-05-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04179721
The ClinicalTrials.gov registry entry for NCT04179721 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,629-participant average among 5 other Alzheimer's Disease and Related Dementias trials with a reported enrollment target (97% lower). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Alzheimer's Disease and Related Dementias appearing as the primary indexed condition, and to 2 interventions - of which PES-4-BPSD Model is the first listed.
NCT04179721 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04179721 about?
NCT04179721 is a clinical study titled "Reducing Behavioral and Psychological Symptoms of Dementia: Hospital Caregivers (Aim 2)". Persons with Alzheimer's Disease and Related Dementias (ADRD) account for 3.2 million hospital admissions per year and have over three times more hospitalizations than those without cognitive impairment, yet hospital caregivers (HCGs) are ill-prepared to manage patients with ADRD with less than 5% r...
What is the current status of trial NCT04179721?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2019-10-22. Estimated completion is 2021-05-18.
What conditions does trial NCT04179721 study?
This clinical trial studies the following conditions: Alzheimer's Disease and Related Dementias.
What interventions are being tested in trial NCT04179721?
The interventions under investigation include: PES-4-BPSD Model (BEHAVIORAL), The attention control condition (BEHAVIORAL).
Who is sponsoring clinical trial NCT04179721?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04179721 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer's Disease and Related Dementias
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intervention to Collect and Utilize Sexual Orientation and Gender Identity (SOGI) Information in Hospice
RECRUITING · NA
-
Translating Data Science to Palliative Care
COMPLETED · NA
-
Smart Lighting for Nursing Home Residents With Dementia
COMPLETED · NA
-
OPTIMAL in NH Residents With Dementia
COMPLETED · NA
-
Preventing Alzheimer's With Cognitive Training
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.